The Future of Cardiovascular Medicine From the Regulatory Perspective
J Am Coll Cardiol
.
2016 Aug 16;68(7):766-9.
doi: 10.1016/j.jacc.2016.07.001.
Author
Robert M Califf
1
Affiliation
1
U.S. Food and Drug Administration, Silver Spring, Maryland. Electronic address: Robert.califf@fda.hhs.gov.
PMID:
27515338
DOI:
10.1016/j.jacc.2016.07.001
No abstract available
Publication types
Editorial
MeSH terms
Biomarkers
Cardiology / instrumentation
Cardiology / legislation & jurisprudence
Cardiology / trends*
Cardiovascular Diseases / therapy*
Evidence-Based Medicine
Humans
Regenerative Medicine
Substances
Biomarkers